Carregant...
Immune Escape Mechanisms and Future Prospects for Immunotherapy in Neuroblastoma
Neuroblastoma (NB) is the most common extracranial solid tumor in childhood with 5-year survival rate of 40% in high-risk patients despite intensive therapies. Recently, adoptive cell therapy, particularly chimeric antigen receptor (CAR) T cell therapy, represents a revolutionary treatment for hemat...
Guardat en:
| Publicat a: | Biomed Res Int |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Hindawi
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5845499/ https://ncbi.nlm.nih.gov/pubmed/29682521 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/1812535 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|